eXeX has developed a platform that helps surgical teams onboard staff and execute procedures with increased efficiency and accuracy. The company combines artificial intelligence and spatial computing and has patented its technology. Its platform has been used in over 2,000 live surgeries across three continents. eXeX plans a commercial launch in early 2025 with initial availability at select hospitals in the United States and the United Kingdom. The company raised $5.8M in Seed funding to accelerate platform development and support the upcoming commercial debut. eXeX is led by CEO Dr. Robert Masson and recently appointed Michael Dykier as CTO.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2024